Funding
Series B · Biotech

InduPro raises $77m Series B for antibody-drug conjugates

The Column Group, Vida Ventures and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

InduPro raised $77 million in Series B financing on August 12. Participants included The Column Group, Vida Ventures, MRL Ventures Fund, Emerson Collective, Euclidean Capital, Solasta Ventures, Sanofi and Eli Lilly and Company. The company develops proximity-guided antibody-drug conjugates for cancer and autoimmune disease.

Funding history

Series B · This round$77M

Sources

  1. InduProprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related